Journal of Clinical and Translational Endocrinology Case Reports (Jun 2017)

Cushing disease in a patient with multiple endocrine neoplasia type 2B

  • Kannan Kasturi,
  • Lucas Fernandes,
  • Martha Quezado,
  • Mary Eid,
  • Leigh Marcus,
  • Prashant Chittiboina,
  • Mark Rappaport,
  • Constantine A. Stratakis,
  • Brigitte Widemann,
  • Maya Lodish

Journal volume & issue
Vol. 4
pp. 1 – 4

Abstract

Read online

Context: Multiple endocrine neoplasia type 2B (MEN2B) is a rare autosomal-dominant cancer syndrome characterized in part by metastatic medullary thyroid cancer (MTC) and pheochromocytoma. Cushing disease is a rare cause of endogenous hypercortisolism in children. Case description: We describe a 21-year-old African-American male who was diagnosed at age 10 with an ACTH-secreting pituitary microadenoma. At age 16 he developed medullary thyroid cancer and was found to have multiple endocrine neoplasia type 2B with the characteristic M918T mutation of the RET proto-oncogene. Following thyroidectomy, he was initiated on Vandetanib, a tyrosine kinase inhibitor, and has since had stable disease over the last 5 years. Conclusions: Our patient is the first individual with MEN2B to be described with Cushing disease. The RET oncogene may play a role in pituitary tumorigenesis; alternatively, the coexistence of these two entities may represent an extremely rare coincidence. Keywords: Hypercortisolemia, Neuroendocrine tumor, Genetic syndrome, RET